According to the information of official website in May 2023, the school has developed more than 70 kinds of new Chinese medicine, transferred 63 scientific and technological achievements, and transferred 65.438+0.45 billion yuan of scientific and technological development and new drugs, and 65.438+0.57 copies of hospital preparations directly under the hospital, with sales of more than 330 million yuan in recent three years. A total of more than 10,000 scientific research projects at all levels10.7 million were approved, and the research funding was about 330 million yuan, which achieved breakthroughs in major national projects such as the major new drug creation project of the Ministry of Science and Technology and the key projects of the regional joint national natural science foundation; There are 6 13 authorized patents and 235 scientific research awards at all levels, including 54 scientific and technological awards at or above the provincial level (including 3 second prizes for national scientific and technological progress and 9 first prizes for provincial and ministerial science and technology). Chai Jin Jieyu Anshen Tablet, which was independently developed, is the first clinical trial innovative Chinese medicine approved by the school as a registered applicant, and has successfully achieved technology transfer. The publication of high-level papers is on the rise. The number of SCI papers has more than doubled since 2020. Through the implementation of the project, the school has promoted the construction of 42 GAP bases in Hunan Province, with a planting area of 700,000 mu and an annual output value of 700 million yuan. He undertook 137 educational, teaching and scientific research projects at or above the provincial level and won 14 national and provincial teaching achievement awards.